RxDoctor Payments DataLook up a doctor →

Sirtaz Sibia, DO

Ophthalmology · Boynton Beach, FLNPI 1679518195

Payments from drug & device makers

$444,813in general payments, 2019–2025

Across 526 payments — averaging $845.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dompe Farmaceutici S.p.a.$322K
  • Argenx US, Inc.$91K
  • Alcon$7K
  • NEW World Medical,inc.$4K
  • Surgical Specialties Corporation (US), Inc. (dba Corza Medical)$4K
  • AbbVie$3K
  • plus $14K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Dompe Farmaceutici S.p.a.14$321,841
Argenx US, Inc.75$91,024
Alcon57$6,955
NEW World Medical,inc.29$4,044
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)3$3,750
AbbVie(2 entities)125$3,295
Katena Products, Inc. (dba Corza Medical)1$2,500
Johnson & Johnson Surgical Vision, Inc.22$1,712
Mallinckrodt Hospital Products Inc.23$1,345
Glaukos Corporation17$1,150
Bausch & Lomb Americas Inc.18$1,060
Bausch & Lomb, A Division Of Bausch Health US, LLC21$977
Amgen(2 entities)20$936
Sight Sciences, Inc.12$746
Rayner Intraocular Lenses Limited10$572
Apellis Pharmaceuticals, Inc.8$491
ANI Pharmaceuticals, Inc.10$415
Rxsight Inc2$345
Dompe US, Inc.6$268
Quidel Corporation2$233
Ocular Therapeutix, Inc.6$198
Novartis8$142
Aerie Pharmaceuticals, Inc.7$133
Regeneron1$123
Shire North American Group Inc4$79
Kala Pharmaceuticals, Inc.3$68
Oyster Point Pharma, Inc.3$64
Tarsus Pharmaceuticals, Inc.2$40
Carl Zeiss Meditec AG2$39
Harrow Eye, LLC2$36
Genentech USA, Inc.2$30
Biotissue Holdings Inc.2$28
Alcon Research LLC1$28
Tearlab Corp2$27
Lensar, Inc.1$27
Regeneron Healthcare Solutions, Inc.1$23
Merz Pharmaceuticals, LLC1$21
Merz North America, Inc.1$20
Astellas Pharma US Inc1$17
Lombart Brothers, Inc.1$12

How this compares

$444,813 in reported general payments places this provider in the 95th percentile of 1,405 ophthalmology providers in Florida.

See all ophthalmology providers in Florida →

Medicare billing

Part B allowed, 2024
$584,299
Medicare patients
1,145
Services billed
7,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other ophthalmology in Boynton Beach

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →